08-Oct-2026 19:02:52

EVONILE PHARMA : TO RAISE RS 900 CR VIA RIGHTS ISSUE

• Board approved fund raising of up to ₹900 Cr via partly paid-up equity shares of face value ₹5 each on a rights basis • Issue size, rights entitlement ratio, issue price, record date and timing to be decided by Board or Rights Issue Committee later • Rights Issue Committee constituted with Vikas Gupta (MD & CEO), Dr. Jagriti Gupta (Non-Executive Director) and Mr. Shashank Sinha (Independent Director) • Postal ballot notice approved to seek shareholder approval for the fund raise • New corporate website launched at www.evonilepharma.com

Novartis India Ltd

← Back to feed